These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32869433)
1. Brain-derived neurotrophic factor is elevated in the blood serum of Crohn's disease patients, but is not influenced by anti-TNF-α treatment-A pilot study. Sochal M; Małecka-Panas E; Gabryelska A; Fichna J; Talar-Wojnarowska R; Szmyd B; Białasiewicz P Neurogastroenterol Motil; 2021 Jun; 33(6):e13978. PubMed ID: 32869433 [TBL] [Abstract][Full Text] [Related]
2. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial. Solati Z; Jazayeri S; Tehrani-Doost M; Mahmoodianfard S; Gohari MR Nutr Neurosci; 2015 May; 18(4):162-8. PubMed ID: 24621065 [TBL] [Abstract][Full Text] [Related]
3. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients. Włodarczyk M; Sobolewska A; Wójcik B; Loga K; Fichna J; Wiśniewska-Jarosińska M World J Gastroenterol; 2014 Jun; 20(22):7019-26. PubMed ID: 24944497 [TBL] [Abstract][Full Text] [Related]
4. Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain. Carpinelli L; Bucci C; Santonicola A; Zingone F; Ciacci C; Iovino P Neurogastroenterol Motil; 2019 Mar; 31(3):e13531. PubMed ID: 30628137 [TBL] [Abstract][Full Text] [Related]
5. C-Reactive protein reduction rate following initiation of anti-tumor necrosis factor α induction therapy predicts secondary loss of response in patients with Crohn's disease. Song JH; Hong SN; Lee JE; Kim K; Kim TJ; Kim ER; Chang DK; Kim YH Scand J Gastroenterol; 2019 Jul; 54(7):876-885. PubMed ID: 31303093 [No Abstract] [Full Text] [Related]
6. Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters. Skibinska M; Kapelski P; Rajewska-Rager A; Pawlak J; Szczepankiewicz A; Narozna B; Twarowska-Hauser J; Dmitrzak-Weglarz M Nord J Psychiatry; 2018 Apr; 72(3):191-196. PubMed ID: 29235396 [TBL] [Abstract][Full Text] [Related]
7. Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability. Guloksuz S; Wichers M; Kenis G; Russel MG; Wauters A; Verkerk R; Arts B; van Os J PLoS One; 2013; 8(3):e60435. PubMed ID: 23544139 [TBL] [Abstract][Full Text] [Related]
8. The interplay of stress and sleep impacts BDNF level. Giese M; Unternaehrer E; Brand S; Calabrese P; Holsboer-Trachsler E; Eckert A PLoS One; 2013; 8(10):e76050. PubMed ID: 24146812 [TBL] [Abstract][Full Text] [Related]
9. Association of brain-derived neurotrophic factor levels and depressive symptoms in young adults with acne vulgaris. He HY; Tian JL; Deng YQ; Xiong X; Xu Y; Liao YM; Fang J; Feng X; Ye X; Li CQ BMC Psychiatry; 2019 Jun; 19(1):193. PubMed ID: 31234814 [TBL] [Abstract][Full Text] [Related]
10. Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease. Sochal M; Ditmer M; Binienda A; Gabryelska A; Białasiewicz P; Talar-Wojnarowska R; Fichna J; Małecka-Wojciesko E Metabolites; 2023 Mar; 13(3):. PubMed ID: 36984890 [TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment. Lotrich FE; Albusaysi S; Ferrell RE Neuropsychopharmacology; 2013 May; 38(6):985-95. PubMed ID: 23303061 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers. Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857 [TBL] [Abstract][Full Text] [Related]
13. Low-Dose Ozone Therapy Improves Sleep Quality in Patients with Insomnia and Coronary Heart Disease by Elevating Serum BDNF and GABA. Li Y; Feng X; Ren H; Huang H; Wang Y; Yu S Bull Exp Biol Med; 2021 Feb; 170(4):493-498. PubMed ID: 33713235 [TBL] [Abstract][Full Text] [Related]
14. The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis. Cheon YH; Lee SG; Kim M; Kim HO; Sun Suh Y; Park KS; Kim RB; Yang HS; Kim JM; Son CN; Kyoung Park E; Kim SH; Lee SI Brain Behav Immun; 2018 Oct; 73():274-281. PubMed ID: 29787856 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia - A controlled cross-sectional study. Ranzolin A; Duarte AL; Bredemeier M; da Costa Neto CA; Ascoli BM; Wollenhaupt-Aguiar B; Kapczinski F; Xavier RM Cytokine; 2016 Aug; 84():25-8. PubMed ID: 27209553 [TBL] [Abstract][Full Text] [Related]
16. Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders. Neupane SP; Lien L; Ueland T; Mollnes TE; Aukrust P; Bramness JG Alcohol; 2015 Aug; 49(5):471-8. PubMed ID: 25873205 [TBL] [Abstract][Full Text] [Related]